GO:0031100 | organ regeneration | 1.97e-04 | 1.00e+00 | 6.472 | 2 | 2 | 44 |
GO:0004151 | dihydroorotase activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0016363 | nuclear matrix | 5.43e-04 | 1.00e+00 | 5.742 | 2 | 7 | 73 |
GO:0000086 | G2/M transition of mitotic cell cycle | 9.58e-04 | 1.00e+00 | 5.332 | 2 | 5 | 97 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0051414 | response to cortisol | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0001940 | male pronucleus | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0014075 | response to amine | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0001939 | female pronucleus | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0007067 | mitotic nuclear division | 2.74e-03 | 1.00e+00 | 4.565 | 2 | 8 | 165 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0000812 | Swr1 complex | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 2 | 7 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 7 |
GO:0033762 | response to glucagon | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 7 |
GO:0031011 | Ino80 complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 8 |
GO:0031122 | cytoplasmic microtubule organization | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 8 |
GO:0043234 | protein complex | 4.41e-03 | 1.00e+00 | 4.217 | 2 | 8 | 210 |
GO:0008266 | poly(U) RNA binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 9 |
GO:0043968 | histone H2A acetylation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 10 |
GO:0007020 | microtubule nucleation | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 2 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 3 | 12 |
GO:0005654 | nucleoplasm | 6.27e-03 | 1.00e+00 | 2.742 | 3 | 55 | 876 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 13 |
GO:0006206 | pyrimidine nucleobase metabolic process | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 2 | 17 |
GO:0071339 | MLL1 complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 18 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 18 |
GO:0003678 | DNA helicase activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 18 |
GO:0000794 | condensed nuclear chromosome | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 18 |
GO:0000278 | mitotic cell cycle | 9.66e-03 | 1.00e+00 | 3.637 | 2 | 35 | 314 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 20 |
GO:0017144 | drug metabolic process | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 2 | 22 |
GO:0042802 | identical protein binding | 1.22e-02 | 1.00e+00 | 3.464 | 2 | 7 | 354 |
GO:0031492 | nucleosomal DNA binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 25 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 2 | 29 |
GO:0016020 | membrane | 1.55e-02 | 1.00e+00 | 2.279 | 3 | 38 | 1207 |
GO:0043195 | terminal bouton | 1.58e-02 | 1.00e+00 | 5.977 | 1 | 1 | 31 |
GO:0007595 | lactation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 32 |
GO:0048146 | positive regulation of fibroblast proliferation | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 1 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 1.88e-02 | 1.00e+00 | 5.722 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 5 | 38 |
GO:0042995 | cell projection | 2.08e-02 | 1.00e+00 | 5.574 | 1 | 2 | 41 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 2.08e-02 | 1.00e+00 | 5.574 | 1 | 2 | 41 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.48e-02 | 1.00e+00 | 5.317 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 6 | 50 |
GO:0006334 | nucleosome assembly | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 5 | 51 |
GO:0005681 | spliceosomal complex | 2.79e-02 | 1.00e+00 | 5.150 | 1 | 2 | 55 |
GO:0032355 | response to estradiol | 2.89e-02 | 1.00e+00 | 5.099 | 1 | 1 | 57 |
GO:0007265 | Ras protein signal transduction | 2.99e-02 | 1.00e+00 | 5.049 | 1 | 3 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 3.09e-02 | 1.00e+00 | 5.001 | 1 | 5 | 61 |
GO:0007565 | female pregnancy | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 64 |
GO:0005200 | structural constituent of cytoskeleton | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 2 | 68 |
GO:0006325 | chromatin organization | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 3 | 70 |
GO:0001889 | liver development | 3.58e-02 | 1.00e+00 | 4.782 | 1 | 1 | 71 |
GO:0070062 | extracellular vesicular exosome | 3.63e-02 | 1.00e+00 | 1.836 | 3 | 43 | 1641 |
GO:0001649 | osteoblast differentiation | 3.73e-02 | 1.00e+00 | 4.722 | 1 | 2 | 74 |
GO:0005815 | microtubule organizing center | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 1 | 77 |
GO:0030529 | ribonucleoprotein complex | 4.13e-02 | 1.00e+00 | 4.574 | 1 | 4 | 82 |
GO:0005634 | nucleus | 4.48e-02 | 1.00e+00 | 1.267 | 4 | 67 | 3246 |
GO:0005829 | cytosol | 4.57e-02 | 1.00e+00 | 1.713 | 3 | 58 | 1787 |
GO:0016887 | ATPase activity | 5.02e-02 | 1.00e+00 | 4.288 | 1 | 6 | 100 |
GO:0007507 | heart development | 5.31e-02 | 1.00e+00 | 4.204 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 5.31e-02 | 1.00e+00 | 4.204 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 5.46e-02 | 1.00e+00 | 4.163 | 1 | 3 | 109 |
GO:0003924 | GTPase activity | 5.95e-02 | 1.00e+00 | 4.037 | 1 | 3 | 119 |
GO:0004672 | protein kinase activity | 6.24e-02 | 1.00e+00 | 3.966 | 1 | 2 | 125 |
GO:0000398 | mRNA splicing, via spliceosome | 6.39e-02 | 1.00e+00 | 3.931 | 1 | 8 | 128 |
GO:0006184 | GTP catabolic process | 6.48e-02 | 1.00e+00 | 3.909 | 1 | 3 | 130 |
GO:0005524 | ATP binding | 6.92e-02 | 1.00e+00 | 2.131 | 2 | 23 | 892 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 7.06e-02 | 1.00e+00 | 3.782 | 1 | 2 | 142 |
GO:0008380 | RNA splicing | 8.17e-02 | 1.00e+00 | 3.565 | 1 | 7 | 165 |
GO:0007283 | spermatogenesis | 8.31e-02 | 1.00e+00 | 3.539 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 8.46e-02 | 1.00e+00 | 3.514 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 8.69e-02 | 1.00e+00 | 3.472 | 1 | 6 | 176 |
GO:0005525 | GTP binding | 9.69e-02 | 1.00e+00 | 3.309 | 1 | 5 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 9.97e-02 | 1.00e+00 | 3.266 | 1 | 1 | 203 |
GO:0006281 | DNA repair | 9.97e-02 | 1.00e+00 | 3.266 | 1 | 19 | 203 |
GO:0019899 | enzyme binding | 1.03e-01 | 1.00e+00 | 3.217 | 1 | 4 | 210 |
GO:0005515 | protein binding | 1.05e-01 | 1.00e+00 | 0.922 | 4 | 76 | 4124 |
GO:0005813 | centrosome | 1.06e-01 | 1.00e+00 | 3.170 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 1.07e-01 | 1.00e+00 | 3.163 | 1 | 7 | 218 |
GO:0019901 | protein kinase binding | 1.13e-01 | 1.00e+00 | 3.073 | 1 | 11 | 232 |
GO:0005730 | nucleolus | 1.20e-01 | 1.00e+00 | 1.682 | 2 | 41 | 1217 |
GO:0003723 | RNA binding | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 11 | 247 |
GO:0005737 | cytoplasm | 1.25e-01 | 1.00e+00 | 1.154 | 3 | 50 | 2633 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.79e-01 | 1.00e+00 | 2.373 | 1 | 10 | 377 |
GO:0005794 | Golgi apparatus | 1.95e-01 | 1.00e+00 | 2.235 | 1 | 5 | 415 |
GO:0010467 | gene expression | 2.46e-01 | 1.00e+00 | 1.868 | 1 | 31 | 535 |
GO:0008270 | zinc ion binding | 3.21e-01 | 1.00e+00 | 1.426 | 1 | 7 | 727 |
GO:0044822 | poly(A) RNA binding | 3.47e-01 | 1.00e+00 | 1.289 | 1 | 25 | 799 |
GO:0044281 | small molecule metabolic process | 3.64e-01 | 1.00e+00 | 1.210 | 1 | 32 | 844 |
GO:0006351 | transcription, DNA-templated | 4.42e-01 | 1.00e+00 | 0.860 | 1 | 9 | 1076 |